Effect of thermal spring water on human dendritic cell inflammatory response

References

• Matz H, Orion E, Wolf R. Balneotherapy in dermatology. Dermatol Ther. 2003;16(2):132–140.12919115
   PubMedGoogle Scholar
• Valitutti S, Castellino F, Musiani P. Effect of sulfurous (thermal) water on T lymphocyte proliferative response. Ann Allergy. 1990;65(6):463–468.2256575
   PubMedGoogle Scholar
• Celerier P, Richard A, Litoux P, Dreno B. Modulatory effects of selenium and strontium salts on keratinocyte-derived inflammatory cytokines. Arch Dermatol Res. 1995;287(7):680–682.8534133
   PubMed Web of Science ®Google Scholar
• Bajgai J, Fadriquela A, Ara J, et al. Balneotherapeutic effects of high mineral spring water on the atopic dermatitis-like inflammation in hairless mice via immunomodulation and redox balance. BMC Complement Altern Med. 2017;17(1):481.29029618
   PubMed Web of Science ®Google Scholar
• Hahn HJ, Kim JS, Kim YH, Lee YB, Yu DS, Kim J-W. Investigation of immune-regulatory effects of mageumsan hot spring via protein microarray in vitro. Ann Dermatol. 2018;30(3):322–330.29853747
   PubMed Web of Science ®Google Scholar
• Lee H-P, Choi Y-J, Cho K-A, et al. Effect of spa spring water on cytokine expression in human keratinocyte hacat cells and on differentiation of CD4+ T cells. Ann Dermatol. 2012;24(3):324–336.22879717
   PubMed Web of Science ®Google Scholar
• Zoller N, Valesky E, Hofmann M, et al. Impact of different spa waters on inflammation parameters in human keratinocyte HaCaT cells. Ann Dermatol. 2015;27(6):709–714.26719640
   PubMed Web of Science ®Google Scholar
• Portales P, Aries MF, Licu D, et al. Immunomodulation induced by avene spring water on Th1- and Th2-dependent cytokine production in healthy subjects and atopic dermatitis patients. Skin Pharmacol Appl Skin Physiol. 2001;14(4):234–242.11464106
   PubMedGoogle Scholar
• Joly F, Charveron M, Aries MF, et al. Effect of Avene spring water on the activation of rat mast cell by substance P or antigen. Skin Pharmacol Appl Skin Physiol. 1998;11(2):111–116.9603662
   PubMedGoogle Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245–252. doi:10.1038/325889521319
   PubMed Web of Science ®Google Scholar
• Collin M, McGovern N, Haniffa M. Human dendritic cell subsets. Immunology. 2013;140(1):22–30. doi:10.1111/imm.1211723621371
   PubMed Web of Science ®Google Scholar
• Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol. 2003;3(12):984–993. doi:10.1038/nri124614647480
   PubMed Web of Science ®Google Scholar
• Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811. doi:10.1146/annurev.immunol.18.1.76710837075
   PubMed Web of Science ®Google Scholar
• Walsh KP, Mills KHG. Dendritic cells and other innate determinants of T helper cell polarisation. Trends Immunol. 2013;34(11):521–530. doi:10.1016/j.it.2013.07.00623973621
   PubMed Web of Science ®Google Scholar
• Kashem SW, Haniffa M, Kaplan DH. Antigen-Presenting Cells in the Skin. Annu Rev Immunol. 2017;35(1):469–499. doi:10.1146/annurev-immunol-051116-05221528226228
   PubMed Web of Science ®Google Scholar
• Clausen BE, Stoitzner P. Functional specialization of skin dendritic cell subsets in regulating T cell responses. Front Immunol. 2015;6:534. doi:10.3389/fimmu.2015.0053426557117
   PubMed Web of Science ®Google Scholar
• Chu -C-C, Di Meglio P, Nestle FO. Harnessing dendritic cells in inflammatory skin diseases. Semin Immunol. 2011;23(1):28–41. doi:10.1016/j.smim.2011.01.00621295490
   PubMed Web of Science ®Google Scholar
• Zaba LC, Krueger JG, Lowes MA. Resident and “inflammatory” dendritic cells in human skin. J Invest Dermatol. 2009;129(2):302–308. doi:10.1038/jid.2008.22518685620
   PubMed Web of Science ®Google Scholar
• Coquerelle C, Moser M. DC subsets in positive and negative regulation of immunity. Immunol Rev. 2010;234(1):317–334. doi:10.1111/j.0105-2896.2009.00887.x20193028
   PubMed Web of Science ®Google Scholar
• Wakim LM, Waithman J, van Rooijen N, Heath WR, Carbone FR. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science. 2008;319(5860):198–202. doi:10.1126/science.115186918187654
   PubMed Web of Science ®Google Scholar
• Lowes MA, Chamian F, Abello MV, et al. Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci U S A. 2005;102(52):19057–19062. doi:10.1073/pnas.050973610216380428
   PubMed Web of Science ®Google Scholar
• Hansel A, Gunther C, Ingwersen J, et al. Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong T(H)17/T(H)1 T-cell responses. J Allergy Clin Immunol. 2011;127(3):787–U456. doi:10.1016/j.jaci.2010.12.00921377044
   PubMed Web of Science ®Google Scholar
• Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG. TN/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity. 2003;19(1):59–70.12871639
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Kraft S, Hanau D, Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol. 1996;106(3):446–453.8648175
   PubMed Web of Science ®Google Scholar
• Raker VK, Domogalla MP, Steinbrink K. Tolerogenic dendritic cells for regulatory T cell induction in man. Front Immunol. 2015;6:569. doi:10.3389/fimmu.2015.0056926617604
   PubMed Web of Science ®Google Scholar
• Naranjo-Gómez M, Raïch-Regué D, Oñate C, et al. Comparative study of clinical grade human tolerogenic dendritic cells. J Transl Med. 2011;9(1):89. doi:10.1186/1479-5876-9-8921658226
   PubMed Web of Science ®Google Scholar
• Navarro-Barriuso J, Mansilla MJ, Martínez-Cáceres EM. Searching for the transcriptomic signature of immune tolerance induction—biomarkers of safety and functionality for tolerogenic dendritic cells and regulatory macrophages. Front Immunol. 2018;9:2062.30298066
   PubMed Web of Science ®Google Scholar
• Guerrero D, Garrigue E. Annales de dermatologie et de venereologie. Eau thermale d’Avène et dermatite atopique: Avène’s thermal water and atopic dermatitis. 2017;144(Suppl 1):S27–s34. doi:10.1016/S0151-9638(17)31040-2
   Google Scholar
• Aries MF, Hernandez-Pigeon H, Vaissiere C, et al. Anti-inflammatory and immunomodulatory effects of Aquaphilus dolomiae extract on in vitro models. Clin Cosmet Investig Dermatol. 2016;9:421–434. doi:10.2147/CCID.S113180
   PubMedGoogle Scholar
• Martin H, Laborel-Preneron E, Fraysse F, et al. Aquaphilus dolomiae extract counteracts the effects of cutaneous S. aureus secretome isolated from atopic children on CD4(+) T cell activation. Pharm Biol. 2016;54(11):2782–2785. doi:10.3109/13880209.2016.117306927180655
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179(4):1109–1118. doi:10.1084/jem.179.4.11098145033
   PubMed Web of Science ®Google Scholar
• Palucka KA, Taquet N, Sanchez-Chapuis F, Gluckman JC. Dendritic cells as the terminal stage of monocyte differentiation. J Immunol. 1998;160(9):4587–4595.9574566
   PubMed Web of Science ®Google Scholar
• Grassi F, Dezutter-Dambuyant C, McIlroy D, et al. Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules. J Leukoc Biol. 1998;64(4):484–493. doi:10.1002/jlb.64.4.4849766629
   PubMed Web of Science ®Google Scholar
• Cheong C, Matos I, Choi J-H, et al. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell. 2010;143(3):416–429. doi:10.1016/j.cell.2010.09.03921029863
   PubMed Web of Science ®Google Scholar
• Sander J, Schmidt SV, Cirovic B, et al. Cellular differentiation of human monocytes is regulated by time-dependent interleukin-4 signaling and the transcriptional regulator NCOR2. Immunity. 2017;47(6):1051–1066.e1012.29262348
   PubMed Web of Science ®Google Scholar
• Cernadas M, Lu J, Watts G, Brenner MB. CD1a expression defines an interleukin-12 producing population of human dendritic cells. Clin Exp Immunol. 2009;155(3):523–533.19220838
   PubMed Web of Science ®Google Scholar
• Faivre V, Lukaszewicz AC, Alves A, Charron D, Payen D, Haziot A. Human monocytes differentiate into dendritic cells subsets that induce anergic and regulatory T cells in sepsis. PLoS One. 2012;7(10):e47209.23071758
   PubMed Web of Science ®Google Scholar
• Gogolak P, Rethi B, Szatmari I, et al. Differentiation of CD1a− and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPARγ. Blood. 2007;109(2):643–652.16968896
   PubMed Web of Science ®Google Scholar
• Zhou LJ, Tedder TF. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol. 1995;154(8):3821–3835.7706722
   PubMed Web of Science ®Google Scholar
• Xia C-Q, Peng R, Beato F, Clare-Salzler MJ. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand J Immunol. 2005;62(1):45–54.16091124
   PubMed Web of Science ®Google Scholar
• Boks MA, Kager-Groenland JR, Haasjes MSP, Zwaginga JJ, van Ham SM, Ten Brinke A. IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction — a comparative study of human clinical-applicable DC. Clin Immunol. 2012;142(3):332–342.22225835
   PubMed Web of Science ®Google Scholar
• Bellanger AP, Pallandre JR, Borg C, Loeffert S, Gbaguidi-Haore H, Millon L. Human monocyte-derived dendritic cells exposed to microorganisms involved in hypersensitivity pneumonitis induce a Th1-polarized immune response. Clin Vaccine Immunol. 2013;20(8):1133–1142.23720369
   PubMedGoogle Scholar
• Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells. Nat Immunol. 2005;6:769.15995707
   PubMed Web of Science ®Google Scholar